Provided by Tiger Trade Technology Pte. Ltd.

Nuvation Bio, Inc.

5.14
-0.4200-7.55%
Post-market: 5.230.0900+1.75%19:57 EDT
Volume:14.83M
Turnover:78.11M
Market Cap:1.80B
PE:-11.72
High:5.66
Open:5.66
Low:5.03
Close:5.56
52wk High:9.75
52wk Low:3.36
Shares:351.12M
Float Shares:264.00M
Volume Ratio:3.80
T/O Rate:5.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4387
EPS(LYR):-0.6000
ROE:-47.81%
ROA:-12.36%
PB:7.11
PE(LYR):-8.57

Loading ...

RBC Adjusts PT on Nuvation Bio to $20 From $19, Maintains Outperform Speculative Risk Rating

MT Newswires Live
·
Aug 07

Analysts Have Conflicting Sentiments on These Healthcare Companies: Intellia Therapeutics (NTLA), Haemonetics (HAE) and Nuvation Bio (NUVB)

TIPRANKS
·
Aug 07

Nuvation Bio Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Nuvation Bio Posts Corporate Presentation Highlighting Ibtrozi ROS1 Lung Cancer Franchise

Reuters
·
Aug 06

Earnings Flash (NUVB) Nuvation Bio Posts Q2 Net Loss of $0.18 per Share, vs. FactSet Est of $0.15 Loss

MT Newswires Live
·
Aug 06

Nuvation Bio Q2 Revenue Beats Estimates on Ibtrozi Growth

Reuters
·
Aug 06

Nuvation Bio Shares Down 2.4% Premarket After Q2 Results

THOMSON REUTERS
·
Aug 06

Nuvation Bio Q2 Income from Pperations USD -51.036 Million

THOMSON REUTERS
·
Aug 06

Nuvation Bio Q2 Revenue USD 31.687 Million VS. Ibes Estimate USD 27.5 Million

THOMSON REUTERS
·
Aug 06

Nuvation Bio Q2 EPS USD -0.18

THOMSON REUTERS
·
Aug 06

Press Release: Nuvation Bio Reports Second Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
Aug 06

Nuvation Bio Q2 EPS $(0.18) Beats $(0.19) Estimate, Sales $31.687M Beat $27.505M Estimate

Benzinga Earnings
·
Aug 06

Nuvation Bio Q2 FY26 Revenue More than Doubled to $31.69 Million

Reuters
·
Aug 06

Nuvation Bio (NUVB) To Share New IBTROZI Data At Two Major Cancer Conferences

Simply Wall St.
·
Aug 05

Nuvation Bio to Present Subgroup Analyses from TRUST-I, TRUST-II Taletrectinib Studies in ROS1+ NSCLC at WCLC 2026

Reuters
·
Aug 04

Nuvation Bio is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jul 27

Nuvation Bio Inc. : H.c. Wainwright Raises Target Price to $21 from $17

THOMSON REUTERS
·
Jul 27

Nuvation Bio Price Target Maintained with a $11.00/share by Wedbush

Dow Jones
·
Jul 23

Nuvation Bio Schedules Q2 2026 Results Call, Business Update Webcast

Reuters
·
Jul 23

Nuvation Bio to Report Second Quarter 2026 Financial Results and Provide Business Update on August 6, 2026

THOMSON REUTERS
·
Jul 23